Head-to-head · Value Score
Alan Meds vs Ivy Rx
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Ivy Rx a 76. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#7 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameIvy Rx
#116 · Grade B- · Fair Price
Est. first month
From $175/mo (starting dose, compounded)
Save ~87% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 76 — an est. $99/mo first month, with no teaser step-up baked in. Ivy Rx isn't out of it: Shoppers who want mainstream telehealth GLP-1 access.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | Ivy Rx |
|---|---|---|
| Value Score | 90 (A) | 76 (B-) |
| Est. first month | $99/mo | From $175/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~87% |
| Semaglutide | $99/mo | From $175/mo (starting dose, compounded) |
| Tirzepatide | $145/mo | From $275/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
Ivy Rx
Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.
Why it's a deal
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
The fine print
- Limited public information on program details
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to Ivy Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.